Yuan Ting, Ni Zhen, Han Chuan, Min Yali, Sun Nina, Liu Caifang, Shi Miao, Lu Wenquan, Wang Na, Du Feng, Wu Qiong, Xie Ning, Shi Yongquan
1State key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710032 China.
The 150 Hospital of the People's Liberation Army, Luoyang, 471000 China.
Cancer Cell Int. 2019 Jan 31;19:24. doi: 10.1186/s12935-019-0739-8. eCollection 2019.
Intestinal metaplasia (IM) is a premalignant lesion associated with gastric cancer. Both animal and clinical studies have revealed that bile acid reflux and subsequent chronic inflammation are key causal factors of IM. Previous studies indicated that SOX2, the key transcription factor in gastric differentiation, was downregulated during IM development while CDX2, the pivotal intestine-specific transcription factor was upregulated significantly. However, it remains unclear whether the downregulation of SOX2 promotes gastric IM emergence or is merely a concomitant phenomenon. In addition, the underlying mechanisms of SOX2 downregulation during IM development are unclear.
Gastric cell lines were treated with deoxycholic acid (DCA) in a dose-dependent manner. The expression of CDX2 and miR-21 in gastric tissue microarray were detected by immunohistochemistry and in situ hybridization. Coimmunoprecipitation and immunofluorescence were performed to ascertain the interaction of SOX2 and CDX2. Luciferase reporter assays were used to detect the transcriptional activity of CDX2, and confirm miR-21 binding to SOX2 3'-UTR. The protein level of SOX2, CDX2 and downstream IM-specific genes were investigated using western blotting. mRNA level of miR-21, SOX2, CDX2 and downstream IM-specific genes were detected by qRT-PCR.
Bile acid treatment could suppress SOX2 expression and simultaneously induce expression of CDX2 in gastric cell lines. Furthermore, we demonstrated that SOX2 overexpression could significantly inhibit bile acid- and exogenous CDX2-induced IM-specific gene expression, including KLF4, cadherin 17 and HNF4α expression. In contrast, SOX2 knockdown had the opposite effect. A dual-luciferase reporter assay demonstrated that SOX2 overexpression could significantly suppress CDX2 transcriptional activity in HEK293T cells. CDX2 and SOX2 could form protein complexes in the nucleus. In addition, bile acid induced the expression of miR-21. The inhibition of SOX2 in bile acid-treated gastric cell lines was rescued by miR-21 knockdown.
These findings suggested that SOX2 can interfere with the transcriptional activity of CDX2 in bile acid-induced IM and that miR-21 might play a key role in this process, which shed new lights in the prevention of gastric cancer.
肠化生(IM)是一种与胃癌相关的癌前病变。动物和临床研究均表明,胆汁酸反流及随后的慢性炎症是IM的关键致病因素。既往研究表明,SOX2作为胃分化中的关键转录因子,在IM发展过程中表达下调,而关键的肠特异性转录因子CDX2则显著上调。然而,SOX2的下调是促进胃IM的出现还是仅仅是一种伴随现象仍不清楚。此外,IM发展过程中SOX2下调的潜在机制也不清楚。
以剂量依赖的方式用脱氧胆酸(DCA)处理胃细胞系。通过免疫组织化学和原位杂交检测胃组织芯片中CDX2和miR-21的表达。进行免疫共沉淀和免疫荧光以确定SOX2和CDX2的相互作用。使用荧光素酶报告基因检测来检测CDX2的转录活性,并确认miR-21与SOX2 3'-UTR的结合。使用蛋白质印迹法研究SOX2、CDX2和下游IM特异性基因的蛋白质水平。通过qRT-PCR检测miR-21、SOX2、CDX2和下游IM特异性基因的mRNA水平。
胆汁酸处理可抑制胃细胞系中SOX2的表达,同时诱导CDX2的表达。此外,我们证明SOX2过表达可显著抑制胆汁酸和外源性CDX2诱导的IM特异性基因表达,包括KLF4、钙黏蛋白17和HNF4α的表达。相反,SOX2敲低则产生相反的效果。双荧光素酶报告基因检测表明,SOX2过表达可显著抑制HEK293T细胞中CDX2的转录活性。CDX2和SOX2可在细胞核中形成蛋白质复合物。此外,胆汁酸诱导miR-21的表达。miR-21敲低可挽救胆汁酸处理的胃细胞系中SOX2的抑制。
这些发现表明,SOX2可干扰胆汁酸诱导的IM中CDX2的转录活性,且miR-21可能在此过程中起关键作用,这为胃癌的预防提供了新的思路。